"Using Epigallocatechin Gallate (EGCG) and Cognitive Training to Modulate Cognitive Performance in Patients With Fragile X Syndrome" (TESFX)
Clinical trial NCT01855971 · COMPLETED
Trial details
- NCT number
- NCT01855971
- Sponsor
- Parc de Salut Mar
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-11
- Primary completion
- 2015-07-31
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.